Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep
Clinical trial NCT05301894 · TERMINATED
Trial details
- NCT number
- NCT05301894
- Sponsor
- Neurocrine Biosciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-07
- Primary completion
- 2025-01-27
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.